Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

NCT01180166 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Concurrent Chemoradiotherapy

Interventions

DRUG: nimotuzumab

Sponsor

Chinese Academy of Medical Sciences